Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

Stopped The study was closed due to investigator discretion based on the lack of perceived clinical activity observed in the study.

Conditions

• Human Papillomavirus
• HPV-16
• High Grade Squamous Intraepithelial Lesion

Interventions

• DRUG: Aldesleukin
• BIOLOGICAL: E6 T Cell Receptor (TCR)

Sponsor

National Cancer Institute (NCI)